Global Contract Research Organization (CROs) Services Market, By Molecule Type (Vaccines, Cell Gene Therapy, Others), Type (Early Phase Development Services, Pharmacokinetics /Pharmacodynamics, Clinic Research Services, Laboratory Services, Physical Characterization, Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing, Consulting Services), Therapeutic Area (Oncology, CNS Disorders, Infectious Diseases, Cardiovascular Diseases, Immunological Disorders, Respiratory Disorders, Diabetes, Other Therapeutic Areas), End User (Pharmaceuticals and Biopharmaceutical Companies, Medical Device Companies, Academic Institutes) – Industry Trends and Forecast to 2030.
Contract Research Organization (CROs) Services Market Analysis and Size
Significant advancements in the healthcare field have been made, including research and drug development. Contract research organization (CRO) services organizations are becoming more and more popular with each passing year. Additionally, market players in the current contract research organization (CRO) services market primarily focus on meeting the customized needs of clinical trials.
Data Bridge Market Research analyses that the contract research organization (CROs) services market, which was USD 50.9 billion in 2022, would rocket up to USD 109.90 billion by 2030 and is expected to undergo a CAGR of 10.10% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Contract Research Organization (CROs) Services Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Molecule Type (Vaccines, Cell Gene Therapy, Others), Type (Early Phase Development Services, Pharmacokinetics /Pharmacodynamics, Clinic Research Services, Laboratory Services, Physical Characterization, Stability Testing, Batch Release Testing, Raw Material Testing, Other Analytical Testing, Consulting Services), Therapeutic Area (Oncology, CNS Disorders, Infectious Diseases, Cardiovascular Diseases, Immunological Disorders, Respiratory Disorders, Diabetes, Other Therapeutic Areas), End User (Pharmaceuticals and Biopharmaceutical Companies, Medical Device Companies, Academic Institutes)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
PPD Inc. (U.S), IQVIA Inc (U.S), ICON Plc (Ireland), Parexel International Corporation (U.S), American Preclinical Services, LLC (U.S), Labcorp Drug Development (U.S), Theorem Clinical research (U.S), WuXi AppTec (China), Syneos Health (U.S), Evotec SE (Germany), Charles River Laboratories (U.S), Syneos Health (U.S.), Medspace (U.S.), FIRMA CLINICAL (U.S.), Frontage Labs (U.S.), Bioagile (India), Novotech (Australia)
|
|
Market Opportunities
|
|
Market Definition
The contract research organization (CRO) offers services that are based on research. It provides contract services to different sectors such as government, medical, pharmaceutical, biotechnical, and other organizations. Data management, clinical operation, regulatory, submission, and quality assurance are some of the major services provided by the industry. Contract research organizations (CROs) assist, and execution experience is needed to complete clinical trials safely and effectively without engaging full-time staff.
Global Contract Research Organization (CROs) Services Market Dynamics
Drivers
- Increasing Cases of Cancer
As per the International Agency for Research on Cancer (IARC) and Global Cancer Observatory (GLOBOCAN), cancer cases are rising. In Asia, China stated 4,285,033 cancer cases in 2018, followed by India and Japan, with 1,157,294 and 883,395 new cases, respectively. There were an expected 18.1 million cancer cases globally in 2020, wherein 9.3 million cases were in men and 8.8 million in women. Thus, because of this increase in numbers, there have been tremendous opportunities for conducting genomic testing devices, oncology clinical trials, and other innovative oncology drugs in CROs. Thus, this factor boosts market growth.
- Increasing Healthcare Expenditure by Organizations
Growing amounts of expenditure are being set aside for R&D in the pharmaceutical and biotech sectors. Growing public and private funding for research activities support the pharmaceutical industry's growth in these regions. In the 2018-19 budget, the Australian government declared $1.3 billion for health and medical research. Under this budget, $248 million was contributed to research on rare diseases, rare cancers, and clinical trial programs, supporting the global market's growth.
Opportunities
- Growing Rate of Product Approvals
There has been an increasing rate of product approvals by authorized organizations that increases the market's growth. In 2020, the approval of 53 drugs, which was only surpassed in 2018 by 59 pharmaceutical agents, was done. The 53 new chemical entities and 13 biologics approved in 2020 involve ten monoclonal antibodies, two antibody–drug conjugates, three peptides, and two oligonucleotides. Furthermore, the FDA has approved 160 drugs from 2018-2020, compared to only 21 in 2010. This increase in the number of approved products globally can cause increased investments by biopharmaceutical companies in developing biosimilars and biologics. Thus, this factor boosts market growth.
Restraints/Challenges
- High Cost of Contract Market Services
Contract market services seem to be very costly. The high labor cost in the market is an important issue that could reduce growth within the predicted forecast period. Creating patents and commercial contracts is complex, and it requires a high labor cost. The high price of this service is restricting the market growth.
This contract research organization (CROs) services market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the contract research organization (CROs) services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
• In 2021, Charles River Laboratories entered into a definitive agreement to acquire Cognate BioServices Inc., a cell and gene therapy contract development and manufacturing organization (CDMO). This agreement aims to increase Charles River's scientific capabilities in the fast-growing cell and gene therapy sector.
Global Contract Research Organization (CROs) Services Market Scope
The contract research organization (CROs) services market is segmented on the basis of molecule type, type, therapeutic area, end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Molecule Type
- Vaccines
- Cell Gene Therapy
- Others
Type
- Early Phase Development Services
- Preclinical
- Toxicology Testing
- Discovery Studies
- Chemistry, Manufacturing and Controls
- Pharmacokinetics /Pharmacodynamics
- Clinic Research Services
- Phase I
- Phase II
- Phase III
- Phase IV
- Laboratory Services
- Analytical Testing
- Bioanalytical Testing
- Physical Characterization
- Stability Testing, Batch Release Testing
- Raw Material Testing
- Other Analytical Testing
- Consulting Services
Therapeutic Area
- Oncology
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Others
- CNS Disorders
- Infectious Diseases
- Cardiovascular Diseases
- Immunological Disorders
- Respiratory Disorders
- Diabetes
- Other Therapeutic Areas
End User
- Pharmaceuticals and Biopharmaceutical Companies
- Medical Device Companies
- Academic Institutes
Contract Research Organization (CROs) Services Market Regional Analysis/Insights
The contract research organization (CROs) services market is analyzed and market size insights and trends are provided by type, therapeutic area, end-user as referenced above.
The countries covered in the contract research organization (CROs) services market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the contract research organization (CROs) services market due to its biosimilar and biologics market's rapid growth. An increase in clinical trial activity will boost the growth in the contract research organization (CRO) services market.
Asia-Pacific is expected to witness significant growth due to the enhanced economic growth of numerous countries in this region, the increasing geriatric population, the rising incidence of chronic diseases, and increasing investments in drug development research activities. Also, the other major factors boosting the market's growth are an increase in outsourcing activities in countries such as India and China because of lower costs and the wide availability of qualified healthcare professionals.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The contract research organization (CROs) services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for contract research organization (CROs) services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the contract research organization (CROs) services market. The data is available for historic period 2011-2021.
Competitive Landscape and Contract Research Organization (CROs) Services Market Share Analysis
The contract research organization (CROs) services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to contract research organization (CROs) services market.
Some of the major players operating in the contract research organization (CROs) services market are:
- PPD Inc. (U.S)
- IQVIA Inc (U.S)
- ICON Plc (Ireland)
- Parexel International Corporation (U.S
- American Preclinical Services, LLC (U.S)
- Labcorp Drug Development (U.S)
- Theorem Clinical research (U.S)
- WuXi AppTec (China)
- Syneos Health (U.S)
- Evotec SE (Germany
- Charles River Laboratories (U.S)
- Syneos Health (U.S.)
- Medspace (U.S.)
- FIRMA CLINICAL (U.S.)
- Frontage Labs (U.S.)
- Bioagile (India)
- Novotech (Australia)
SKU-